Sennosides Tablet
Product Images NDC 87717-501

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sennosides (NDC 87717-501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Morepen Bio Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dosage & Administration (Dosage And Administration)

Dosage & Administration (Dosage And Administration)
Dosage instruction table for Sennosides 8.6 mg oral tablets detailing starting and maximum dosages by age group, including adults and children 12 years and over, children 6 to under 12 years, children 2 to under 6 years, and children under 2 years with the recommendation to consult a doctor.*
FDA Label Image

Indications & Usage (Indications And Usage)

Indications & Usage (Indications And Usage)
A drug facts panel section titled Uses, stating that the product relieves occasional constipation (irregularity) and generally produces a bowel movement in 6-12 hours. The text is in black on a white background with bold headings.*
FDA Label Image

Keep Out Of Reach Of Children (Keep Out Of Reach Of Children)

Keep Out Of Reach Of Children (Keep Out Of Reach Of Children)
A text panel containing a warning to keep the product out of reach of children and advising to seek medical help or contact a Poison Control Center immediately in case of overdose.*
FDA Label Image

Purpose Label (Purpose)

Purpose Label (Purpose)
Drug Facts panel showing the active ingredient Sennosides 8.6 mg per tablet with the purpose listed as laxative.*
FDA Label Image

Primary Display Panel 1000 Tablets (Sennosides 8.6mg Pdp)

Primary Display Panel 1000 Tablets (Sennosides 8.6mg Pdp)
Sennosides 8.6 mg tablets by Morepen Bio Inc, featured in a large container label showing 1000 tablets. The label highlights the active ingredient sennosides 8.6 mg per tablet with a purpose as a laxative, regular strength for constipation relief. Directions for use and warnings are included, along with inactive ingredients and manufacturer information.*
FDA Label Image

Storage And Handling (Storage And Handling)

Storage And Handling (Storage And Handling)
A text panel labeled "Other information" stating each tablet contains 26.9 mg of calcium and storage instructions to keep the product at 25°C (77°F) with allowed temperature excursions between 15-30°C (59-86°F).*
FDA Label Image

Active Ingredient Label (Active Ingredient)

Active Ingredient Label (Active Ingredient)
Drug Facts panel listing the active ingredient Sennosides at 8.6 mg per tablet, identified as a laxative. The text format separates 'Active ingredient (in each tablet)' on the left and 'Purpose' on the right.*
FDA Label Image

Inactive Ingredients (Inactive Ingredients)

Inactive Ingredients (Inactive Ingredients)
Drug facts panel listing inactive ingredients of Sennosides 8.6 mg tablets. The inactive ingredients include croscarmellose sodium, dibasic calcium phosphate, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone, and polyethylene glycol.*
FDA Label Image

Questions & Comments (Question Or Comments)

Questions & Comments (Question Or Comments)
A text panel providing contact information for questions or comments regarding the product, including a toll-free phone number, email address, and FDA contact details for reporting issues or inquiries.*
FDA Label Image

Warnings (Warnings)

Warnings (Warnings)
Warning text panel for an over-the-counter Sennosides 8.6 mg oral tablet. The panel includes cautions about not using laxative products for longer than one week without doctor direction, advises consulting a doctor before use with certain symptoms, and instructs to stop use and ask a doctor if rectal bleeding or lack of bowel movement occurs. It also advises pregnant or breastfeeding individuals to consult a health professional and to keep the product out of reach of children, with instructions to seek medical help in case of overdose.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.